New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment.
The only potentially curative options for gastric cancer involve endoscopic or surgical resection, with adjunctive systemic ...
HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...
A sensor that requires no nanoscale patterning detects single molecules of a breast cancer protein at concentrations 250 ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
In recent years, the field of oncology has increasingly acknowledged cancer as a metabolic disorder with significant ...
A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...
Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...
Researchers at Tezpur University, Assam, have discovered chemical signatures in blood that distinguish gallbladder cancer cases with and without gallstones. This finding could lead to early detection ...
A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are emerging as important for guiding ovarian cancer therapy, including ...
Early detection and prevention of cancer can save lives, but current tools often fall short because of suboptimal accuracy and limited accessibility. The Fred Hutch Cancer Center aims to change that ...
When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback